Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Summary

This study is being conducted to assess the safety, tolerability, and immunogenicity of the CodaVax-H1N1 influenza vaccine as compared to active and placebo controls when administered to healthy adults.

Timeline

Start

2017-02-21

Primary completion

2018-05-29

Completion

2018-09-14

Drugs

Indications